vimarsana.com

Page 14 - குறிப்பிட்ட கால இடைவெளியில் தொழிலாளர் படை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Welcome To IANS Live - LatestNews - Microsoft introduces ‘Cloud for retail’ service

Photo Credit: IANS IANSLive San Francisco, Jan 14 (IANS) As retailers fast embrace digital solutions to help better understand their customers and deliver an agile and resilient supply chain, Microsoft has introduced the private preview of Cloud for Retail . To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 14-January-2021

Welcome To IANS Live - SCIENCE - Google working on to fix Pixel 4a 5G touchscreen issue

According to Android Police, some Pixel 4a units started exhibiting touchscreen issues with Android 11, and it seems like a similar problem spread to the Pixel 4a 5G following the December security patch.Many

Baker: No Known Threat to State Buildings Related to Biden Inaugu

DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2, Lead Candidates Described in Science Publication

DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2, Lead Candidates Described in Science Publication Core technology includes promising bivalent single-domain antibodies simultaneously targeting two surface structures of the viral spike protein. Lead candidates DIOS-202 and DIOS-203 are engineered for high potency and their potential to avoid the emergence of escape mutants. DIOS-202 and DIOS-203 entered into accelerated development to initiate clinical studies later this year. DiosCURE Therapeutics SE announced a publication in Science describing its core technology of multivalent single-chain antibodies with a unique molecular mode-of-action to inactivate SARS-CoV-2 virions. An international team led by scientists at the University of Bonn developed and characterized the lead candidates, which are exclusively licensed by DiosCURE.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.